Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development

计划入组 16 人 · 首次发布于 2018 年 12 月 14 日

Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase

计划入组 120 人 · 首次发布于 2012 年 10 月 29 日

Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders

计划入组 198 人 · 首次发布于 2008 年 5 月 22 日

Na+/K+ ATPase inhibitors (heart failure)

ATPase modulator (Lycera)

NA-901

KIM IVANA K

United States

Dr. Tapas K. Das Gupta

K-Group Beta, Inc.

United States

Windtree Therapeutics to Present Istaroxime Data at ThinkEquity Conference

Seismic Pharmaceuticals Commences Global Phase 3 Trial of Istaroxime for Cardiogenic Shock

Windtree Therapeutics Partners with New Growth Advisors to Explore Strategic Options for Istaroxime